Recruiting
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
NCT04848844
Arrhythmias, Cardiac, Arrythmia
Hamburg, Free and Hanseatic City of Hamburg, Germany
View Trial Details
Recruiting
NCT Number: NCT06504225
EVEROLD LONG TERM FOLLOW-UP
Long Term Follow up of EVEROLD study
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Chu Amiens, Amiens, France
Loading trial locations.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Informed patients participating to the EVEROLD study
- Patient having completed the EVEROLD M12 follow-up visit
- Patient agreeing to participate in the observational study
Exclusion criteria
- Opposition to the use his medical data
- Patient under legal protection
Treatment and study plan
Primary outcomes
-
Patient survival
Time frame: up to 12 years
Patient survival at last follow-up
-
Graft survival
Time frame: up to 12 years
Graft survival at last follow-up
Secondary outcomes
-
Rejection rate
Time frame: up to 12 years
Biopsy proven rejection
-
Infection rate
Time frame: up to 12 years
All infections requiring hospitalization
-
Major cardiovascular events
Time frame: up to 12 years
-
Cancer rate
Time frame: up to 12 years
Skin cancer, solid organ tumor and hematological cancer
-
Hospitalization
Time frame: up to 12 years
Number of hospitalization, hospital stay, reason for hospitalization
-
eGFR
Time frame: up to 12 years
estimated GFR (MDRD and CKD-EPI)
Study contacts
Contact information is provided by the study sponsor or research team.
Christelle RATAJCZAK
CONTACT
Yannick Le Meur
CONTACT
Sponsors and collaborators
Lead sponsor
University Hospital, Brest
Other
Registry information
Official study title
Long-term Evaluation of the Value of Using an MTor Inhibitor (everolimus) for the Minimisation of Anticalceurins in Old-for-old Kidney Transplantation
Acronym: EVEROLD FUP
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Jul 16, 2024
- Registry last updated
- Feb 6, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Not Yet Recruiting
Evaluation at 5 and 10 Years of Renal Transplant Patients
NCT05469906
Transplant; Complication, Failure
Brest, France
View Trial Details
Completed
Retroperitoneoscopic Donor Nephrectomy
NCT03893656
Hernia, Pathological Conditions, Anatomical
Samsun, Turkey (Türkiye)
View Trial Details